Investigació
Projectes de recerca:
The use of gamma interferon in immune-modulation and prevention of infection in burn patients: A Phase III assaig multicèntric europeu; Co-Investigador, Servei de Cirurgia Plàstica i Cremats, Vall d’Hebron Hospital, Barcelona, 1994-1995
Effects of IGF-1/BP3 on muscle catabolism; Co-investigador, University of Texas; 1997-1999
Comparison of Biobrane versus topical antibiotic treatment in partial thickness burns Co-investigador, University of Texas Medical Branch Galveston, Texas 1997-1998
Sensitivity and specificity of broncho alveolar lavage and protected bronchial brush in the diagnosi of pneumonia in burn patients; Co-Investigador, University of Texas Medical Branch, Galveston, Texas, USA, 1997-1999
Effects of rGH on burn scars; Co-investigator, University of Texas; 1998
Selective decontamination of digestive tract: effects on the inflammatory response and infection outcomes; Investigador principal, University of Texas, 1997-1999
Cost-efficacy of cultured epidermal grafts; Investigador principal, University of Texas; 1997-1999
Validation of nerve guides in nerve regeneration, Co-investigador, University of Groningen; 1999-2002
Determination of the catabolic response with micro-dialysis, Mid-Essex Research Foundation, Investigador principal, UK; 2002-2004
Evaluation of the effects of platelet rich plasma and platelet derived growth factors on wound Healing, Investigador principal, VHIR, Barcelona; 2006-present
Antibiotics pharmaco-dynamics in burn patients: Microdialysis, Fundació Mútua Madrilenya ; Investigador principal, Madrid; 2007-2008
Tractament de cremades de gruix parcial amb teràpia d’ones de xoc premudes; Co-investigador, Institut de Recerca Vall d´Hebron, 2009
Gabapentin treatment in burn patients, Co-investigador, VHIR, Barcelona; 2011-present
GLYADERM Assaig Multicèntric Europeu, VHIR, Barcelona (Promotor, Nederlanse Brandwonden Stichting, University of Gent); Investigador principal, 2010-present
Determination of P.I.A. in burn patients; Investigador principal, VHIR, Barcelona; 2012-present
Effects of Bosentan on the inflammatory and fibrotic response; Investigador principal, VHIR, Barcelona; 2010-present
Phase II Clinical Trial of Prontosan-Gel study, BBraun Dexon, Investigador principal. 2012-present
Phase III Clinical Trial, Birken Oleogel study; Coordinador Internacional d’Assaig Clínic Multicèntric, 2012-present
Observational study TenderWet in burns, Hartmann, Investigador principal, 2013-present
Tractament de cicatrius hipertròfiques amb ones de xoc; Investigador principal, VHIR, Barcelona, 2013-present
Estudi Aquacel-Globe, Convatec, Investigador principal, VHIR, Barcelona, 2013-present
